Partial protection to respiratory syncytial virus (RSV) elicited in mice by intranasal immunization using live staphylococci with surface-displayed RSV-peptides

Vaccine. 2000 Jun 1;18(24):2743-52. doi: 10.1016/s0264-410x(00)00063-3.

Abstract

A live bacterial vaccine-delivery system based on the food-grade bacterium Staphylococcus carnosus was used for delivery of peptides from the G glycoprotein of human respiratory syncytial virus, subtype A (RSV-A). Three peptides, corresponding to the G protein amino acids, 144-159 (denoted G5), 190-203 (G9) and 171-188 (G4 S), the latter with four cysteine residues substituted for serines, were expressed by recombinant means as surface-exposed on three different bacteria, and their surface accessibility on the bacteria was verified by fluorescence-activated cell sorting (FACS). Intranasal immunization of mice with the live recombinant staphylococci elicited significant anti-peptide as well as anti-virus serum IgG responses of balanced IgG1/IgG2a isotype profiles, and upon viral challenge with 10(5) tissue culture infectious doses(50) (TCID(50)), lung protection was demonstrated for approximately half of the mice in the G9 and G4 S immunization groups. To our knowledge, this is the first study in which protective immunity to a viral pathogen has been evoked using food-grade bacteria as vaccine-delivery vehicles.

MeSH terms

  • Administration, Intranasal
  • Amino Acid Sequence
  • Animals
  • Antibodies, Viral / biosynthesis
  • Antigens, Viral / immunology*
  • Cell Separation
  • Flow Cytometry
  • HN Protein*
  • Humans
  • Immunoglobulin G / biosynthesis
  • Mice
  • Molecular Sequence Data
  • Protein Structure, Secondary
  • Recombinant Fusion Proteins
  • Respiratory Syncytial Viruses / immunology*
  • Staphylococcus*
  • Surface Properties
  • Viral Envelope Proteins / genetics
  • Viral Envelope Proteins / immunology*
  • Viral Fusion Proteins / genetics
  • Viral Fusion Proteins / immunology*
  • Viral Proteins / genetics
  • Viral Proteins / immunology*
  • Viral Vaccines / administration & dosage
  • Viral Vaccines / immunology*

Substances

  • Antibodies, Viral
  • Antigens, Viral
  • HN Protein
  • Immunoglobulin G
  • Recombinant Fusion Proteins
  • Viral Envelope Proteins
  • Viral Fusion Proteins
  • Viral Proteins
  • Viral Vaccines
  • attachment protein G